171 related articles for article (PubMed ID: 3782814)
21. Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma.
von Zons P; Crowley-Nowick P; Friberg D; Bell M; Koldovsky U; Whiteside TL
Clin Diagn Lab Immunol; 1997 Mar; 4(2):202-7. PubMed ID: 9067656
[TBL] [Abstract][Full Text] [Related]
22. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay.
Wahlberg BJ; Burholt DR; Kornblith P; Richards TJ; Bruffsky A; Herberman RB; Vujanovic NL
J Immunol Methods; 2001 Jul; 253(1-2):69-81. PubMed ID: 11384670
[TBL] [Abstract][Full Text] [Related]
23. Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays.
Williams BA; Wang XH; Keating A
Cytotherapy; 2010 Nov; 12(7):951-60. PubMed ID: 20230219
[TBL] [Abstract][Full Text] [Related]
24. Psychoneuroimmunology and Natural Killer Cells: The Chromium-Release Whole-Blood Assay.
Fletcher MA; Barnes Z; Broderick G; Klimas NG
Methods Mol Biol; 2018; 1781():209-220. PubMed ID: 29705850
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxicity of normal and activated rat monocytes analyzed by flow cytometry.
Stehling O; Grau V; Steiniger B
Cytometry A; 2003 Dec; 56(2):81-8. PubMed ID: 14608635
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric measurement of NK cell cytotoxicity.
Hoshino T; Hara A; Inoue M; Honda J; Imai Y; Oizumi K; Yokoyama MM
J Clin Lab Immunol; 1991 Sep; 36(1):39-43. PubMed ID: 1668860
[TBL] [Abstract][Full Text] [Related]
27. A versatile flow-based assay for immunocyte-mediated cytotoxicity.
Rabinovich PM; Zhang J; Kerr SR; Cheng BH; Komarovskaya M; Bersenev A; Hurwitz ME; Krause DS; Weissman SM; Katz SG
J Immunol Methods; 2019 Nov; 474():112668. PubMed ID: 31525367
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of NK cell-mediated cytotoxicity using radioactive and flow cytometric cytotoxicity assays.
Langhans B; Ahrendt M; Nattermann J; Sauerbruch T; Spengler U
J Immunol Methods; 2005 Nov; 306(1-2):161-8. PubMed ID: 16202423
[TBL] [Abstract][Full Text] [Related]
29. Standardization of a micro-cytotoxicity assay for human natural killer cell lytic activity.
Mariani E; Monaco MC; Sgobbi S; de Zwart JF; Mariani AR; Facchini A
J Immunol Methods; 1994 Jun; 172(2):173-8. PubMed ID: 8034970
[TBL] [Abstract][Full Text] [Related]
30. A MitoTracker Green-based flow cytometric assay for natural killer cell activity: variability, the influence of platelets and a comparison of analytical approaches.
Hopkinson K; Williams EA; Fairburn B; Forster S; Flower DJ; Saxton JM; Pockley AG
Exp Hematol; 2007 Mar; 35(3):350-7. PubMed ID: 17309815
[TBL] [Abstract][Full Text] [Related]
31. A real-time digital bio-imaging system to quantify cellular cytotoxicity as an alternative to the standard chromium-51 release assay.
Fassy J; Tsalkitzi K; Salavagione E; Hamouda-Tekaya N; Braud VM
Immunology; 2017 Apr; 150(4):489-494. PubMed ID: 28004383
[TBL] [Abstract][Full Text] [Related]
32. Cell-mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexinV/propidium iodide colabeling by fluorosphere-adjusted counts on three-color flow cytometry.
Ozdemir O; Ravindranath Y; Savaşan S
Cytometry A; 2003 Nov; 56(1):53-60. PubMed ID: 14566939
[TBL] [Abstract][Full Text] [Related]
33. Measuring natural killer cell cytotoxicity by flow cytometry.
Wong WY; Wong H; Cheung SP; Chan E
Pathology; 2019 Apr; 51(3):286-291. PubMed ID: 30803738
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric mast cell-mediated cytotoxicity assay: a three-color flow cytometric approach using monoclonal antibody staining with annexin V/propidium iodide co-labeling to assess human mast cell-mediated cytotoxicity by fluorosphere-adjusted counts.
Ozdemir O
J Immunol Methods; 2011 Feb; 365(1-2):166-73. PubMed ID: 21215748
[TBL] [Abstract][Full Text] [Related]
35. A Novel Method for Assessment of Natural Killer Cell Cytotoxicity Using Image Cytometry.
Somanchi SS; McCulley KJ; Somanchi A; Chan LL; Lee DA
PLoS One; 2015; 10(10):e0141074. PubMed ID: 26492577
[TBL] [Abstract][Full Text] [Related]
36. Optimization of cytotoxic assay by target cell retention of the fluorescent dye carboxyfluorescein diacetate (CFDA) and comparison with conventional 51CR release assay.
Provinciali M; Di Stefano G; Fabris N
J Immunol Methods; 1992 Oct; 155(1):19-24. PubMed ID: 1401964
[TBL] [Abstract][Full Text] [Related]
37. A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells.
Flieger D; Gruber R; Schlimok G; Reiter C; Pantel K; Riethmüller G
J Immunol Methods; 1995 Mar; 180(1):1-13. PubMed ID: 7897241
[TBL] [Abstract][Full Text] [Related]
38. A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells.
Zimmermann SY; Esser R; Rohrbach E; Klingebiel T; Koehl U
J Immunol Methods; 2005 Jan; 296(1-2):63-76. PubMed ID: 15680151
[TBL] [Abstract][Full Text] [Related]
39. A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity.
Kandarian F; Sunga GM; Arango-Saenz D; Rossetti M
J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829424
[TBL] [Abstract][Full Text] [Related]
40. Comparing individual NK cell activity in vitro.
Sierich H; Eiermann T
Curr Protoc Immunol; 2013; Chapter 14():Unit 14.32.. PubMed ID: 23392637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
